Nonlinear Inverse Association Seen for Step Count, Peak Cadence With MACE
THURSDAY, Aug. 7, 2025 -- There are nonlinear, inverse associations for step count and peak cadence with the risk for major adverse cardiovascular events (MACE) among individuals with hypertension, according to a study published online Aug. 6 in the European Journal of Preventive Cardiology.
Sonia W.M. Cheng, Ph.D., from the University of Sydney, and colleagues obtained data for participants with established hypertension from the U.K. Biobank accelerometry substudy. Participants wore an accelerometer for seven consecutive days. Dose-response associations were examined for daily step count and peak 30-minute cadence with the risk for MACE among 36,192 participants.
The researchers observed nonlinear inverse dose-response associations for daily step count and peak 30-minute cadence with the risk for MACE during a follow-up of 7.8 years. The average risks for MACE, heart failure, myocardial infarction, and stroke were 17.1, 22.4, 9.3, and 24.5 percent lower, respectively, with each 1,000-step increase in daily step count. For people with and without hypertension, the magnitude of associations with increasing step count and stepping intensity was comparable for overall MACE, heart failure, and stroke, but lower for myocardial infarction.
"This study is one of the first to demonstrate a dose-response relationship between daily step count and major problems of the heart and blood vessels," supervising author Emmanuel Stamatakis, Ph.D., also from the University of Sydney, said in a statement. "In a nutshell, we found that, if you live with high blood pressure, the more you walk with greater intensity, the lower your risk for future serious cardiovascular events."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.